TrialHaematologica2021

Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial.

Gail J Roboz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.